{
    "organizations": [],
    "uuid": "c5e885a768b4169569a35b8c0bb20a428a897f23",
    "author": "",
    "url": "https://www.reuters.com/article/brief-capricor-therapeutics-says-fda-has/brief-capricor-therapeutics-says-fda-has-granted-cap-1002-rmat-designation-idUSFWN1PV0T9",
    "ord_in_thread": 0,
    "title": "BRIEF-Capricor Therapeutics Says ‍FDA Has Granted CAP-1002 RMAT Designation",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 13 PM / in 11 minutes BRIEF-Capricor Therapeutics Says ‍FDA Has Granted CAP-1002 RMAT Designation Reuters Staff 1 Min Read \nFeb 5 (Reuters) - Capricor Therapeutics Inc: \n* CAPRICOR THERAPEUTICS SAYS ‍FDA HAS GRANTED CAP-1002 REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION - SEC FILING Source text : ( bit.ly/2s6RQ09 ) Further company coverage:",
    "published": "2018-02-05T14:13:00.000+02:00",
    "crawled": "2018-02-05T14:33:09.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "therapeutic",
        "say",
        "granted",
        "rmat",
        "designation",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "capricor",
        "therapeutic",
        "inc",
        "capricor",
        "therapeutic",
        "say",
        "granted",
        "regenerative",
        "medicine",
        "advanced",
        "therapy",
        "rmat",
        "designation",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}